Safety of immune checkpoint inhibitors in patients with preexisting autoimmune disorders.

被引:0
|
作者
Kumar, Rohit
Chan, Abigail Sy
Bandikatla, Sudeepthi
Mudra, Sarah
Ranjan, Smita
Ngo, Phuong
机构
[1] Univ Louisville, James Brown Graham Canc Ctr, Div Hematol & Med Oncol, Louisville, KY 40292 USA
[2] Univ Louisville, Louisville, KY 40292 USA
[3] Univ Louisville Hosp, Louisville, KY USA
[4] Univ Louisville, Sch Med, Louisville, KY 40292 USA
[5] Univ Louisville, James Graham Brown Canc Ctr, Div Hematol & Med Oncol, Louisville, KY 40292 USA
关键词
D O I
10.1200/JCO.2021.39.15_suppl.e14568
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14568
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Use of PD-1 pathway inhibitors among patients with non-small cell lung cancer (NSCLC) and preexisting autoimmune disorders.
    Leonardi, Giulia Costanza
    Gainor, Justin F.
    Azimi, Roxana S.
    Riess, Jonathan
    Rizvi, Hira
    Hellmann, Matthew David
    Awad, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Autoimmune phenomena and disease in cancer patients treated with immune checkpoint inhibitors
    Tocut, Milena
    Brenner, Ronen
    Zandman-Goddard, Gisele
    AUTOIMMUNITY REVIEWS, 2018, 17 (06) : 610 - 616
  • [43] Is it possible to use immune checkpoint inhibitors in patients with autoimmune or inflammatory disease?
    Danlos, Francois-Xavier
    Lambotte, Olivier
    M S-MEDECINE SCIENCES, 2018, 34 (6-7): : 516 - 518
  • [44] Immune checkpoint inhibitors for patients with pre-existing autoimmune diseases
    Maeda, Osamu
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2023, 85 (01) : 33 - 34
  • [45] Autoimmune Skin Diseases and Immune Checkpoint Inhibitors
    Fattore, Davide
    Potestio, Luca
    Genco, Lucia
    Pages, Cecile
    Ortiz, Ariadna
    Fabbrocini, Gabriella
    Sibaud, Vincent
    CRITICAL REVIEWS IN IMMUNOLOGY, 2022, 42 (03) : 11 - 22
  • [46] Cancer immunotherapy in patients with preexisting autoimmune disorders
    Marco Donia
    Magnus Pedersen
    Inge Marie Svane
    Seminars in Immunopathology, 2017, 39 : 333 - 337
  • [47] Cancer immunotherapy in patients with preexisting autoimmune disorders
    Donia, Marco
    Pedersen, Magnus
    Svane, Inge Marie
    SEMINARS IN IMMUNOPATHOLOGY, 2017, 39 (03) : 333 - 337
  • [48] Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study
    Paderi, Agnese
    Fancelli, Sara
    Caliman, Enrico
    Pillozzi, Serena
    Gambale, Elisabetta
    Mela, Marinella Micol
    Doni, Laura
    Mazzoni, Francesca
    Antonuzzo, Lorenzo
    CURRENT ONCOLOGY, 2021, 28 (05) : 3259 - 3267
  • [49] Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients
    Vucinic, Damir
    Skocilic, Iva
    Golcic, Marin
    Dobrila-Dintinjana, Renata
    Kolak, Maja
    Jerkovic, Ivona
    Tesar, Eleonora Cini
    Ferari, Ani Mihaljevic
    Redjovic, Arnela
    Marusic, Jasna
    Kolovrat, Doris
    Mikolasevic, Ivana
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (03):
  • [50] Safety of Immune Checkpoint Inhibitors for Cancer Therapy in IBD Patients
    Llano, Ernesto M.
    Rubin, David T.
    Luke, Jason
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S406 - S407